Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Brain spectroscopy reveals that N-acetylaspartate is associated to peripheral sensorimotor neuropathy in type 1 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Mortality and complications after treatment of acute diabetic Charcot foot

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Pathophysiology and management of diabetic gastroenteropathy

    Research output: Contribution to journalReviewResearchpeer-review

  2. Suboptimal Piperacillin-Exposure Following Bolus Administration in Children with Chemotherapy-Induced Fever

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. Regional gastrointestinal pH profile is altered in patients with type 1 diabetes and peripheral neuropathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Tine Maria Hansen
  • Birgitte Brock
  • Anne Juhl
  • Asbjørn Mohr Drewes
  • Henrik Vorum
  • Carl Uggerhøj Andersen
  • Poul Erik Jakobsen
  • Jesper Karmisholt
  • Jens Brøndum Frøkjær
  • Christina Brock
View graph of relations

AIMS: Emerging evidence shows, that distal symmetric peripheral neuropathy (DSPN) also involves alterations in the central nervous system. Hence, the aims were to investigate brain metabolites in white matter of adults with diabetes and DSPN, and to compare any cerebral disparities with peripheral nerve characteristics.

METHODS: In type 1 diabetes, brain metabolites of 47 adults with confirmed DSPN were compared with 28 matched healthy controls using proton magnetic resonance spectroscopy (H-MRS) in the parietal region including the sensorimotor fiber tracts.

RESULTS: Adults with diabetes had 9.3% lower ratio of N-acetylaspartate/creatine (NAA/cre) in comparison to healthy (p < 0.001). Lower NAA/cre was associated with lower sural (p = 0.01) and tibial (p = 0.04) nerve amplitudes, longer diabetes duration (p = 0.03) and higher age (p = 0.03). In addition, NAA/cre was significantly lower in the subgroup with proliferative retinopathy as compared to the subgroup with non-proliferative retinopathy (p = 0.02).

CONCLUSIONS: The association to peripheral nerve dysfunction, indicates concomitant presence of DSPN and central neuropathies, supporting the increasing recognition of diabetic neuropathy being, at least partly, a disease leading to polyneuropathy. Decreased NAA, is a potential promising biomarker of central neuronal dysfunction or loss, and thus may be useful to measure progression of neuropathy in diabetes or other neurodegenerative diseases.

Original languageEnglish
JournalJournal of Diabetes and its Complications
Issue number4
Pages (from-to)323-328
Number of pages6
Publication statusPublished - 1 Apr 2019

    Research areas

  • Central nervous system, Diabetes neuropathy, Magnetic resonance spectroscopy, Metabolites, N-acetylaspartate, Peripheral neuropathy

ID: 56500324